Featured Products
IMMUNOME™
High-throughput platform of 1600+ immunomodulatory proteins
CTA array
High-throughput protein array of
200+ cancer-testis antigens
Custom array
Flexible miniaturised format for
high-throughput screening
Technical Performance
Highly reproducible
This graph shows the CV variation of the intra-protein replicates run on Immunome slides (dark blue) against Protein Array PX (blue). We can observe that the mean CV% for Immunome was only 3.9% and 37% for the protein array PX.
Immunome is also capable of consistently producing these low CVs across different samples and cases, allowing us to establish the validity of the Immunome array.
Excellent signal-to-noise ratio
From left to right: the signal ratio for Protein Array PX, as compared to the Immunome array. As you can see, the Immunome signals are much cleaner, and has very low background noise, therefore making it easy to interpretable biomarkers.
*Independent validation data courtesy of KTH, Stockholm.
Exceptional consistency
The graph shows the relationship between the mean RFU and Immunoglobin G (IgG) dilution across different samples. We can clearly see here that they remain consistent across dilution levels and across individual slides. This means that the same RFUs across different slides will be observed if the same dilution levels are used.
Picomolar sensitivity
The serum antibody detection range limit is in the 10 pg/ml range, although the dynamic range is from 4 to 5 orders of magnitude.
1996 – 2018 © Sengenics All rights reserved | Sengenics Corporation Pte Ltd. Registered in Singapore no. 201734100D | Sengenics UK Ltd. Registered in England and Wales No 11016361